Moleac is thrilled to announce the successful launch of NeuroAiD™II in Mongolia! A significant milestone in our ambition to make NeuroAiD™II available to more patients every year.
We are proud to partner with Monos Group, Mongolia’s leading healthcare and pharmaceutical company, founded in 1990 and recognized for its innovation, research, and nationwide impact.
Together, we are committed to advancing clinical knowledge in neurorehabilitation and improving neurological recovery outcomes for patients in Mongolia.
Know more about Monos Trade Ltd at www.monos.mn/en
Know more about NeuroAiD™ at www.moleac.com/neuroaidii/
